Survival and Long-Term Cause-Specific Mortality Associated With Stage IA Lung Adenocarcinoma After Wedge Resection vs. Segmentectomy: A Population-Based Propensity Score Matching and Competing Risk Analysis
Author:
Funder
National Natural Science Foundation of China
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference26 articles.
1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer.,2015
2. Gene aberrations for precision medicine against lung adenocarcinoma;Saito;Cancer Sci.,2016
3. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med.,2011
4. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group;Ginsberg;Ann Thorac Surg.,1995
5. Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage I non-small cell lung cancer: a meta-analysis;Hou;Ther Adv Respir Dis.,2016
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effectiveness and safety of segmentectomy vs. wedge resection for the treatment of patients with operable non‑small cell lung cancer: A meta‑analysis and systematic review;Oncology Letters;2024-05-24
2. Micropapillary or solid component predicts worse prognosis in pathological IA stage lung adenocarcinoma: A meta-analysis;Medicine;2023-12-08
3. Résection infra-lobaire dans le CBNPC de stade précoce : vers un nouveau standard thérapeutique ? Critères de qualité et recommandations européennes;Revue des Maladies Respiratoires Actualités;2023-10
4. Real-world survival outcomes of wedge resection versus lobectomy for cT1a/b cN0 cM0 non-small cell lung cancer: a single center retrospective analysis;Frontiers in Oncology;2023-08-17
5. The impact of medication belief on adherence to infliximab in patients with Crohn’s disease;Frontiers in Pharmacology;2023-08-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3